Investigator-Led Trials On The Rise in Russia
The number of investigator-led trials is rising in Russia as scientific knowledge grows and doctors work more closely together. But the methodological framework is still patchy and companies planning to get involved in such trials need to know the possible pitfalls and be prepared to support investigators in their work.
You may also be interested in...
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.
InflaRx and Relief Therapeutics/NeuroRx are investigating potential new treatments for COVID-19-induced pneumonia and for coronavirus-related ARDS.